Chronic Bronchitis News and Research

RSS

Genetic factors in smoking also increase risk of chronic bronchitis

Smoking is a known risk factor for respiratory diseases like chronic bronchitis, but genes also play a significant role in its development, according to researchers in Sweden, who studied more than 40,000 Swedish twins to determine the extent to which behavior, environment and genes each play a role ion the development of chronic bronchitis.

1 Mar 2008

Scientists recreate rhinovirus infection in mice - hope of new asthma treatments

Scientists have been able to recreate rhinovirus infection, which is behind most common colds, in a small animal for the first time.

4 Feb 2008

Women who smoke at increased risk of chronic obstructive pulmonary disease

Here's another reason not to smoke, especially for women: chronic obstructive pulmonary disease (COPD).

3 Jan 2008

Women and chronic obstructive pulmonary disease

Women have made a good deal of welcome progress in the last several decades, but at least one advance is unwanted: chronic obstructive pulmonary disease (COPD) is on the rise in women in prevalence, morbidity and mortality.

17 Dec 2007

New technique reveals insights into lung disease

Doctors at the Universities of Nottingham and Leicester are collaborating in the use of a magnetic resonance technique to image and quantify the air spaces inside the lungs - and the results of their research may lead to a link between childhood disease and later degenerative lung disease.

14 Dec 2007

New technique reveals insights into lung disease

Doctors at the Universities of Leicester and Nottingham are collaborating to use a magnetic resonance technique to image and quantify the air spaces inside the lungs.

10 Dec 2007

Secondhand smoke does damage lungs

It's not a smoking gun, but it's smoking-related, and it's there in bright medical images: evidence of microscopic structural damage deep in the lungs, caused by secondhand cigarette smoke.

27 Nov 2007

New human rhinovirus associated with pediatric respiratory tract infection in Germany

Using a rapid, sensitive, and inexpensive diagnostic tool called MassTag PCR, scientists at Columbia University Mailman School of Public Health's Center for Infection and Immunity implicated a new human rhinovirus as the cause of severe pediatric respiratory tract infections in Europe.

21 Nov 2007

Safety of nebulized Formoterol in COPD

Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), supporting the use of Perforomist (formoterol fumarate) Inhalation Solution as a safe and effective maintenance treatment for COPD patients.

24 Oct 2007

Self-management education for patients with chronic obstructive pulmonary disease

Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.

17 Oct 2007

Fraunhofer pharmaceutical agent speeds drug development

It takes a great deal of time and money to develop a new drug. At Biotechnica in Hanover from October 9 to 11, the Fraunhofer Life Sciences Alliance will demonstrate how a pharmaceutical agent can make its way more quickly from the research laboratory to the pharmacy.

8 Oct 2007

Gene-chip studies provide new leads in treating abnormal lung development in premature newborns

Some 20 to 40 percent of extremely premature infants suffer abnormal lung development leading to bronchopulmonary dysplasia, a chronic lung disease that can cause long-term breathing problems.

4 Oct 2007

Link between nicotine and atherosclerosis

It's well known that smoking cigarettes increases risk for a host of serious health problems from cancer to heart disease. Now a new study from Weill Cornell Medical College in New York City looks at how they do their dirty work by contributing to atherosclerosis, or hardening of the arteries. The evidence points to nicotine, the addictive chemical in cigarettes.

11 Sep 2007

GSK receives FDA 'not approvable letter' for Advair for COPD

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).

9 Aug 2007

Some smokers have genetic predisposition to develop chronic obstructive pulmonary disease

Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease (COPD) if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues.

12 Jul 2007

People with chronic obstructive pulmonary disease have greater arterial stiffness

The researchers also found that those COPD patients with osteoporosis, a common complication of the respiratory disease, had even greater arterial stiffness. These premature signs of aging may explain why COPD patients are at greater risk for cardiovascular disease.

19 Jun 2007

Seniors and heart disease: Lower cholesterol, cut your risk

A new report from RetireSafe's Senior Center for Health and Security examines how statins can be an effective treatment for lowering cholesterol and cutting the overall risk of heart disease in America's seniors. among Americans.

24 May 2007

Clinical trial data for Perforomist Inhalation solution

Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).

22 May 2007

FDA approves Dey, L.P.'s NDA for chronic obstructive pulmonary disease inhalation solution

Dey, L.P. has announced that the Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Perforomist (formoterol fumarate) Inhalation Solution for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).

15 May 2007

Tens of thousands of Americans die each year from secondhand tobacco smoke

While the health risks associated with indoor secondhand smoke are well documented, little research has been done on exposure to toxic tobacco fumes outdoors.

4 May 2007

Chronic Bronchitis News and Research

Genetic factors in smoking also increase risk of chronic bronchitis

Scientists recreate rhinovirus infection in mice - hope of new asthma treatments

Women who smoke at increased risk of chronic obstructive pulmonary disease

Women and chronic obstructive pulmonary disease

New technique reveals insights into lung disease

New technique reveals insights into lung disease

Secondhand smoke does damage lungs

New human rhinovirus associated with pediatric respiratory tract infection in Germany

Safety of nebulized Formoterol in COPD

Self-management education for patients with chronic obstructive pulmonary disease

Fraunhofer pharmaceutical agent speeds drug development

Gene-chip studies provide new leads in treating abnormal lung development in premature newborns

Link between nicotine and atherosclerosis

GSK receives FDA 'not approvable letter' for Advair for COPD

Some smokers have genetic predisposition to develop chronic obstructive pulmonary disease

People with chronic obstructive pulmonary disease have greater arterial stiffness

Seniors and heart disease: Lower cholesterol, cut your risk

Clinical trial data for Perforomist Inhalation solution

FDA approves Dey, L.P.'s NDA for chronic obstructive pulmonary disease inhalation solution

Tens of thousands of Americans die each year from secondhand tobacco smoke

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News